Shilpa Medicare · NSE: SHILPAMED · BSE: 530549
Q3 FY22 results · Oct–Dec 2021
Shilpa Medicare reported revenue from operations of ₹272.30 crore (up 42.4% from Q3 FY21) and net profit of ₹9.54 crore (up 24.3% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 272.30 | 191.25 | +42.4% | 295.27 | −7.8% |
| Other income | 5.48 | 8.61 | −36.3% | 1.28 | +327.5% |
| Total income | 277.78 | 199.85 | +39.0% | 296.55 | −6.3% |
| Profit before tax | 20.00 | 10.58 | +89.0% | 32.59 | −38.6% |
| Net profit for the period | 9.54 | 7.67 | +24.3% | 19.88 | −52.0% |
| Attributable to shareholders of the company | 9.56 | — | — | 19.96 | −52.1% |
| EPS, basic (₹) | 1.13 | 0.94 | +20.2% | 2.45 | −53.9% |
| Net margin (%) | 3.5 | 4.0 | 6.7 |
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 276.64 | 171.30 | +61.5% | 285.87 | −3.2% |
| Other income | 13.00 | 8.61 | +51.1% | 9.11 | +42.8% |
| Total income | 289.64 | 179.91 | +61.0% | 294.98 | −1.8% |
| Profit before tax | 48.34 | 24.87 | +94.4% | 60.98 | −20.7% |
| Net profit for the period | 36.77 | 16.88 | +117.8% | 43.62 | −15.7% |
| EPS, basic (₹) | 4.36 | 2.07 | +110.6% | 5.35 | −18.5% |
| Net margin (%) | 13.3 | 9.9 | 15.3 |
Consolidated
- Filed with BSE
- 09 Feb 2022, 18:53 IST
- Board meeting
- 08 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Feb 2022, 18:53 IST
- Board meeting
- 08 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE